Clinical trials recruiting for Small Cell Lung Carcinoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase IIII Study of AL8326 in Small Cell Lung Cancer
  NCT06247605 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
  NCT06177925 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
  NCT06586957 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
• A Study of Hospital-at-Home for People Receiving Tarlatamab
  NCT06957314 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of LY4175408 in Participants With Advanced Cancer
  NCT07046923 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 54 locations
• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
  NCT06131840 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 48 locations
• Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
  NCT05620342 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Biology of Young Lung Cancer Study: The YOUNG LUNG Study
  NCT05265429 · Phase: Not specified · Ages: 15 Years and older · Sex: All (male and female) · 4 locations
• DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
  NCT05882058 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 59 locations
• Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial
  NCT07015892 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
  NCT07509333 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 70 Years · Sex: All (male and female) · 1 location
• Molecular Analysis and Treatment Options of SCLC
  NCT05945745 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
  NCT06247163 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
  NCT04199741 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
  NCT07006727 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 7 locations
• Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
  NCT06481813 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer
  NCT06529081 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
  NCT07155200 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
  NCT05450965 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
  NCT04585750 · Phase: Phase 1, Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 154 locations

Related conditions

Trials recruiting for Small Cell Lung Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Small Cell Lung Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.